BioCardia, Inc. (BCDA) Operating cash flow 2016–2025
BioCardia, Inc. (BCDA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$7.4MFY2025 · since FY2016: -$5.5M → -$7.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.4M | +5.7% |
| FY2024 | -$7.9M | +20.9% |
| FY2023 | -$10.0M | +5.6% |
| FY2022 | -$10.6M | -1.9% |
| FY2021 | -$10.4M | +16.1% |
| FY2020 | -$12.4M | -30.8% |
| FY2019 | -$9.4M | +14.7% |
| FY2018 | -$11.1M | -27.7% |
| FY2017 | -$8.7M | -57.0% |
| FY2016 | -$5.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BCDA financial trends
BCDA RevenueBCDA Net incomeBCDA Net marginBCDA Gross profitBCDA Gross marginBCDA Operating incomeBCDA Operating marginBCDA Free cash flowBCDA Capital expendituresBCDA Return on equityBCDA Stock buybacksBCDA Dividends paidBCDA Total assetsBCDA Total liabilitiesBCDA Shareholders’ equityBCDA overview →